Facilities

Home - Investor - Regulatory affairs
Regulatory affairs


Our regulatory affairs team includes more than 70 people. They have successfully completed dossier submission to the US and European countries. Several ANDAs and INDs (for NCE) have been approved by international regulatory authorities. One of our products Azithromycin tablet is listed on WHO prequalified medicine list, and more than 20DMFs and CEPs are available.


Copyright  HEC Pharma Co., Ltd